CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Total Revenue	$ 833,036	$ 267,766
Operating Costs and Expenses
Amortization of patents and proprietary technology	16,285	32,010
Cost of revenue	63,484	37,257
Administrative and marketing expense	538,959	646,696
Research and development expense	271,380	312,191
Total Operating Costs and Expenses	890,108	1,028,154
Loss from operations	(57,072)	(760,388)
Other Income (Expense)
Interest expense	(283,975)	(316,980)
Interest income	2,087	47
Gain on extinguishment of debt	147,645
Gain (Loss) on change in fair value of derivative liabilities	(383,743)	171,227
Net Other Income (Expense)	(517,986)	(145,706)
Net Loss	$ (575,058)	$ (906,094)
Basic and Diluted Loss Per Common Share	$ (0.01)	$ (0.01)
Basic and Diluted Weighted-Average Common Shares Outstanding	96,954,697	92,863,464
Engineering, Contract and Testing Revenue [Member]
Total Revenue	$ 283,036	$ 267,766
Licensing Fees Revenue [Member]
Total Revenue	$ 550,000